Analyze Diet

Safety of ceftiofur sodium administered intramuscularly in horses.

Abstract: Ceftiofur sodium, a broad-spectrum cephalosporin antibiotic, was evaluated for safe use in horses. Male or female horses were allotted to groups and were given either saline solution (control), or 2.2, 6.6, or 11 mg of an aqueous solution of ceftiofur sodium/kg of body weight/d, IM, for 30 or 31 days. These dosages are expressed in terms of the ceftiofur free acid, and represent 1 to 5 times the proposed therapeutic dosage (2.2 mg/kg/d) administered for 3 times the maximal recommended duration of 10 days. Some of the horses were euthanatized and necropsied on day 31 or 32. The other horses were evaluated for an additional 30 days, and some were euthanatized and necropsied on day 60. The following types of data were collected: clinical observation; physical examination; pelleted food consumption; body weight; hematologic, serum biochemical, and urinalysis findings; organ weight; gross necropsy observations; and histopathologic findings. Ceftiofur sodium was generally well tolerated at the exaggerated doses and treatment durations used in these safety studies. Slight to mild decrease in pelleted food consumption was detected in horses given 6.6 or 11 mg of ceftiofur sodium/kg/d. Decreased food consumption began on day 2 and lasted for approximately 9 to 12 days. Generally, mild skeletal muscle irritation was detected by gross and microscopic examination of the injection sites of horses given ceftiofur sodium. Prevalence and severity of the muscle irritation tended to increase with increasing concentration of the dosing solution.(ABSTRACT TRUNCATED AT 250 WORDS)
Publication Date: 1992-11-01 PubMed ID: 1466520
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article
  • Randomized Controlled Trial

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study evaluates the safety of the antibiotic ceftiofur sodium in horses. It found the drug is generally well-tolerated even at high doses, but can cause decreased food consumption and mild skeletal muscle irritation at the injection sites.

Research Context

  • The study aims to assess the safety of the antibiotic ceftiofur sodium when used in horses. Ceftiofur sodium is a broad-spectrum cephalosporin antibiotic that fights many different types of bacterial infections.
  • The research is important because ensuring the safety of any medication used in animals is crucial, and specifically, knowing the side effects related to ceftiofur sodium in horses contributes valuable information in veterinary medicine.

Methodology

  • Horses, both male and female, were split into groups. Some were given a saline solution as a control, while others were given different doses (2.2, 6.6, or 11 mg/kg/day) of ceftiofur sodium for 30 or 31 days.
  • These dosages were expressed in terms of the free acid form of ceftiofur, representing 1 to 5 times the proposed therapeutic dosage.
  • The researchers measured several types of data including clinical observation; physical examination; pelleted food consumption; body weight; hematologic, serum biochemical, and urinalysis findings; organ weight; gross necropsy observations; and histopathologic findings.
  • Some horses were euthanized on days 31 or 32 for a necropsy, while others were observed for another 30 days before being euthanized and necropsied on day 60.

Findings

  • Overall, ceftiofur sodium was found to be generally well-tolerated by the horses, even at exaggerated doses and treatment durations.
  • However, a slight to mild decrease in food consumption was noted in horses given 6.6 or 11 mg of ceftiofur sodium/kg/day. This decrease in appetite started on the second day and lasted approximately 9 to 12 days.
  • Additionally, a mild irritation in the skeletal muscles was detected through gross and microscopic examination of the injection sites in horses given the antibiotic. The prevalence and severity of the muscle irritation appeared to increase with higher concentrations of the dose.
  • No other significant adverse effects were noted, indicating that Ceftiofur sodium is generally safe to use in horses, but caution is advised regarding possible appetite loss and muscle irritation.

Cite This Article

APA
Mahrt CR. (1992). Safety of ceftiofur sodium administered intramuscularly in horses. Am J Vet Res, 53(11), 2201-2205.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 53
Issue: 11
Pages: 2201-2205

Researcher Affiliations

Mahrt, C R
  • Drug Safety Research Unit, Upjohn Co., Kalamazoo, MI 49001.

MeSH Terms

  • Animals
  • Body Weight / drug effects
  • Cephalosporins / administration & dosage
  • Cephalosporins / toxicity
  • Eating / drug effects
  • Female
  • Horse Diseases / chemically induced
  • Horse Diseases / pathology
  • Horses / anatomy & histology
  • Horses / blood
  • Injections, Intramuscular / veterinary
  • Male
  • Muscular Diseases / chemically induced
  • Muscular Diseases / pathology
  • Muscular Diseases / veterinary
  • Organ Size / drug effects

Citations

This article has been cited 3 times.
  1. Bonilla AG, Causeret L, Torrent-Crosa A. Pharmacokinetics of ceftiofur in the metacarpophalangeal joint after standing intravenous regional limb perfusion in horses. Can Vet J 2021 Sep;62(9):975-981.
    pubmed: 34475583
  2. Kauter A, Epping L, Semmler T, Antao EM, Kannapin D, Stoeckle SD, Gehlen H, Lübke-Becker A, Günther S, Wieler LH, Walther B. The gut microbiome of horses: current research on equine enteral microbiota and future perspectives. Anim Microbiome 2019 Nov 13;1(1):14.
    doi: 10.1186/s42523-019-0013-3pubmed: 33499951google scholar: lookup
  3. Ci X, Li H, Song Y, An N, Yu Q, Zeng F, Deng X. Ceftiofur regulates LPS-induced production of cytokines and improves LPS-induced survival rate in mice. Inflammation 2008 Dec;31(6):422-7.
    doi: 10.1007/s10753-008-9094-ypubmed: 18989766google scholar: lookup